Cardiovascular Disease News Archive
In hemodialysis patients, only non-traditional risk factors such as C-reactive protein predicted non-fatal myocardial infarction and other atherosclerotic events, researchers report.
High levels of worry in Mexican-origin women studied tied to risk of higher BMI, obesity, blood pressure.
No patient had a 25% or greater rise in serum creatinine 48 hours after receiving a median 13 mL of contrast for diagnostic coronary angiography, with an additional 13 mL for percutaneous coronary intervention.
Increased incidence of acute myocardial infarction in first 7 days after positive respiratory viral diagnosis
Men who smoked just one cigarette/day had 46% of excess relative risk of smoking 20/day.
Prospective studies needed to examine long-term effects of chronic marijuana use on CV health.
Second Grade I statement questions use of ABI for screening for peripheral artery disease, CVD risk.
Each 10 mg/dL increase in serum levels of total and HDL cholesterol are associated with a significant 5% and 14% increased risk of high-grade PCa, respectively.
Study compared guidelines for atherosclerotic cardiovascular disease prevention.
Mineralocorticoid receptor antagonists found to lower hospital readmission risk in patients with heart failure and concomitant diabetes or renal insufficiency.
Study finds that 44% of hospital readmissions among hemodialysis patients are related to pulmonary edema, with initial pulmonary edema-related hospitalization the strongest predictor for readmission due to the condition.
Male gender, age and LDL-C were all found to be independently related to atherosclerosis.
Given low cost and risk, meditation may be viable adjunct to guideline-directed treatment.
Intensive BP drops may lower cardiovascular risks in both patients with and without diabetes.
The ACC released decision pathways to help clinicians manage bleeding in patients taking oral anticoagulants.
Urinary ceruloplamin has potential to be a chronic kidney disease biomarker for patients with sickle cell anemia.
Among patients admitted to a coronary care unit, the highest quartile of serum cystatin C levels was associated with a 9.6-fold increased risk of AKI compared with the lowest quartile.
High doses of iron are associated with a significantly higher risk of cardiovascular disease, regardless of the dose of erythropoiesis-stimulating agent.
Severe hypoglycemia is associated with coronary heart disease, cardiovascular mortality, and cancer mortality.
For patients with diabetes, there was a significant decrease in hospitalization rates for acute coronary syndrome, cardiac dysrhythmia, heart failure, and certain strokes.
Coffee consumption was affiliated with more positives than negatives across a wide range of health outcomes.
In a study of hospitalized US veterans, AKI was associated with a 23% increased risk of heart failure compared with the absence of AKI.
Both total intake of nuts and consumption of peanuts/tree nuts and walnuts tied to lower risk.
Reduced frequency of MACE for patients receiving statins, especially high-intensity statins.
Each 0.1 increase in WHR is associated with a 1.7-fold increased risk of cardiovascular death.
From 1995 to 2015, the prevalence of hypertension and diabetes among patients starting hemodialysis increased from 67.9% to 87.6% and from 43.1% to 59.6%, respectively.
US veterans who underwent coronary artery bypass grafting versus percutaneous coronary intervention prior to starting dialysis had a 28% lower risk of death.
In any Diabetes Prevention Program treatment group, statin use tied to increased diabetes risk.
27% of CV deaths in diabetes patients with atherosclerotic CVD are categorized as sudden death.
Greater improvement in CHD risk factors for combined intervention versus either alone.
Direct oral anticoagulants not linked to increased risk of major bleeding, death in venous thromboembolism
Exposure to androgen-deprivation therapy was associated with a nearly 2-fold increased risk of heart failure among men without pre-existing cardiovascular disease.
Hemodialysis patients had higher rates of infective endocarditis than peritoneal dialysis and kidney transplant patients.
Overall, therapy was received by just 30.9% of those prescribed PCSK9 inhibitors.
Findings in a large study of long-term low-dose aspirin users.
The researchers found that over the study period statin use was associated with an 18% lower risk of all-cause mortality and non-significantly lower risk of CVD events and stroke.
Adherence to beta-blockers may not be as beneficial to patients after myocardial infarction.
The results demonstrated a tendency for a decrease in LDL-C level at 24 weeks in the ANA group, and improvement was mediated through the suppression of apoB-100 synthesis.
Administration of exenatide in patients with type 2 diabetes at a wide range of cardiovascular risk appeared not to cause an increase in their overall cardiovascular risk.
The researchers found that there was no evidence of an independent correlation between impaired cognitive function and antihypertensive use.
No associations were seen between low-density lipoprotein cholesterol levels and cognitive changes in an exploratory analysis.
The use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo.
The researchers found that there was an increase in NOAC use over time, warfarin use did not change, and overall anticoagulant use increased.
Older age, Indian ethnicity, hypertension, chronic kidney disease, creatinine level, glomerular filtration rate, and history of stroke were associated with prevalent retinal emboli in multivariable-adjusted analysis.
Canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo.
In a study, the risk for heart failure was 81% higher among patients who received androgen deprivation therapy.
High-carb diets were associated with a 28% increased risk of death vs low-carb diets.
Liraglutide-treated patients were 22% less likely than placebo recipients to experience a composite outcome of renal events.
ApoB is a superior marker of cardiovascular disease risk than LDL-C.
The researchers found patients on intensive blood pressure treatment fared as well as those on standard care.
Cardiovascular death, stroke, or myocardial infarction occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group.
The addition of V/S ratio to age, eGFR, BNP, antiplatelet agents, and HbA1c significantly improved classification performance for CVD.
The six-month cumulative incidence of myocardial infarction was 2.0% and 0.7% in patients with cancer and controls, respectively.
Those who were light or moderate alcohol consumers, compared with lifestyle abstainers, had a reduced risk of all-cause mortality and CVD mortality.
The researchers found that after a median period of 4.4 years, the median change in estimated glomerular filtration rate did not differ significantly between the CPAP and usual-care groups.
Atrial fibrillation risk increases as estimated glomerular filtration rate decreases and albuminuria increases, according to a new meta-analysis.
The researchers found that estimated sodium intake greater than 3.7 g per day correlated with larger left atrial and left ventricular dimensions.
During a mean follow-up of 9.7 years, 40% of patients died; 50% among those with depression vs 38% among those without depression.
Discontinuation of statin therapy between 3 and 6 months after an index ischemic stroke was associated with a higher risk of recurrent stroke within one year after statin discontinuation.
Compared with usual care, HIIT correlated with a 20% reduction in the prevalence of modifiable CVD risk factors.
Continued statin prescriptions after an adverse reaction were associated with a lower incidence of death and cardiovascular events.
Addition of CCTA-detected obstructive coronary artery disease to risk factors ups prediction of MACE.
Participants with CHIP had a four-fold increased risk compared with noncarriers in 2 retrospective case-control cohorts for evaluation of early-onset myocardial infarction.
A healthy diet should focus on healthy foods rich in nutrients that can help reduce disease risk, like poly- and monounsaturated vegetable oils, nuts, fruits, vegetables, whole grains, fish, and others.
For patients who can't tolerate or afford hypertension medications, the research suggested some herbal alternatives: tiankuijiangya, zhongfujiangya, jiangyabao, and jiangya.
Patients suffering from mental distress experienced higher all-cause cardiovascular deaths.
Hypogonadal testicular cancer survivors had 15 times higher odds of metabolic syndrome than their eugonadal counterparts.
Anemic patients were 41% and 80% more likely to have coronary artery disease and peripheral artery disease than non-anemic patients.
The researchers found that during 13,509 patient-years of follow-up, 3166 patients had 405 first bleeding events.
The researchers found that the primary outcome of first occurrence of an adjudicated major cardiovascular event occurred in 8.5% and 9.3% of patients in the degludec and glargine groups, respectively.
Male sex, filling β-blocker and antiplatelet agent prescriptions, and attending cardiac rehabilitation within 30 days of discharge were factors associated with filling high-intensity statin prescriptions in 2014.
Study findings suggest that the medication may offer renal protection.
The likelihood of dying within 30 days of being admitted for care was 1.5% lower at major teaching facilities compared with non-teaching hospitals.
Treatment with evacetrapib did not result in a lower rate of cardiovascular events than placebo among patients with high-risk vascular disease.
The researchers found no significant difference in coronary heart disease event rates among the groups.
The investigators also found that the risk of cardiovascular disease in obese people rose with the number of metabolic abnormalities.
No significant differences were seen between statin users and non-users in the rates of other adverse events.
Interventions are needed to increase high-intensity statin use and adherence after myocardial infarction.
Reduced glomerular filtration rate ranked similarly to high total cholesterol as a risk factor for disability-adjusted life years.
Baseline nutritional status does not influence the effect of randomized long-term multivitamin use on major CVD events.
The largest numbers of diet-related cardiometabolic deaths were related to high sodium, low nuts/seeds, high processed meats, low seafood omega-3 fats, low vegetables, low fruits, and high SSBs.
An increasing number of midlife vascular risk factors was significantly associated with elevated amyloid SUVR; this association was not significant for late-life risk factors.
The primary outcome of CVD occurred in 303 participants (11.8%) in the vitamin D group and 293 participants (11.5%) in the placebo group.
Hyperglycemia from genetics increases the risk of coronary artery disease separately from type 2 diabetes and other CAD risk factors.
Among patients with the highest variation in body weight, the risk of a coronary event, cardiovascular event, death, myocardial infarction, and stroke was increased.
Statin intolerance was associated with a 36% higher rate of recurrent MI, a 43% higher rate of CHD events, and a 15% lower rate of all-cause mortality.
Action taken to mitigate risks associated with ESA use and changes in payment policy did not result in a relative increase in death or major cardiovascular events.
Both evolocumab and inclisiran reduced the risk of cardiovascular events and lowered LDL cholesterol levels.
The USPSTF guidelines focus statin recommendations on 38% of high-risk African American individuals at the expense of not recommending treatment in nearly 25% of African Americans.
Men taking PDE5 lowered their risk of hospitalization and mortality after a heart attack by 33%.
In short-term treatment duration, there was no increased risk of myocardial infarction stroke or heart failure using DPP-4i vs SU/TZD.
Overweight or obesity increases cardiometabolic risk, but the number and type of CRFs varied substantially by age, even among participants with morbid obesity.
Patients with early and frequent nephrology visits before dialysis initiation had about a 10% lower risk for major adverse cardiovascular events.
No evidence to determine whether taking herbal medications cause complications among patients with CVD.
No deaths, lead failures, losses of capture, or ventricular arrhythmias occurred during MRI.
Plasma TMAO levels among patients predict both near- and long-term risks of incident cardiovascular events.
Participants with high TG and low HDL levels had a 1.32-fold greater HR for CHD than those with normal TG and normal HDL levels.
In a large study, testosterone replacement therapy was associated with a 33% lower risk of cardiac and stroke events among hypogonadal men.
The presence of CAC among individuals aged between 32 and 46 years was associated with increased risk of fatal and nonfatal CHD during 12.5 years of follow-up.
Those without traditional cardiovascular risk factors are disproportionately prone to these cardiac diseases in the setting of alcohol abuse.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)